Ohio State University: Early phase 1 study in Sexual Assault, Alcohol Intoxication (220 participants)
Ohio State University: Early phase 1 study in Sexual Assault, Alcohol Intoxication (220 participants). Its enrollment of 220 is above the median of 80 (79th percentile). Dated 10 days ago, it is in the active follow-up window. Score 65/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 220 · 79th percentile of 8,879 ClinicalTrialStartPulse records · 2.8x the median
Free preview: all 14 published fields of this record are shown below. Locked: 499 related US ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Ohio State University |
| Sponsor type | Academic and hospital |
| Study | Examining the Role of Sensitivity to Uncertain Threat and Alcohol Response in Risk for Alcohol Use Disorder Following Sexual Assault in College Women |
| NCT ID | NCT07894289 |
| Phase | Early phase 1 |
| Status | not yet recruiting |
| Conditions | Sexual Assault; Alcohol Intoxication |
| Intervention types | drug |
| Target enrollment | 220 |
| Site countries | United States |
| Posted | 2026-10-26 |
| Planned start | 2026-12 |
| Event | Newly registered study |
| Event date | 2026-10-26 |
| enrollment percentile | 79th of 8,879 (median 80, 2.8x median) |
| Peer records CSV (500 US records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Ohio State University
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Ohio State University + 500 US peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-26
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (US first): Sanofi · Pfizer · National Institute of Arthritis and Musculoskeletal and Skin · Apple Inc. · National Cancer Institute (NCI) · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Ohio State University and 2,512 US peers
- US ClinicalTrialStartPulse records like this one: 2,512
- Ohio State University's enrollment: 79th percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every US peer: $502,400 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
65 / 100 Score
- Posted in the last two weeks.
- 220 participants planned.
- Not yet recruiting: vendors still being chosen.
What is the ClinicalTrialStartPulse record for Ohio State University?
Ohio State University registered a Early phase 1 study (NCT07894289) in Sexual Assault targeting 220 participants, posted 2026-10-26.
How does Ohio State University compare to other ClinicalTrialStartPulse records?
Its enrollment of 220 sits in the upper half (79th percentile) of 8,879 records; the median is 80. It is fresh: dated 10 days ago, inside the window where early outreach matters most.
Ohio State University vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Ohio State University | US | 220 | 79th | 2026-10-26 |
| Rush University Medical Center | US | 140 | 68th | 2026-10-30 |
| Yale University | US | 139 | 68th | 2026-11-02 |
| City of Hope Medical Center | US | 100 | 60th | 2026-11-03 |
Related records
- Applied Biology, Inc.
- Applied Biology, Inc.
- City of Hope Medical Center
- M.D. Anderson Cancer Center
- Rush University Medical Center
- Apreo Health, Inc.
- Mclean Hospital
- University of Wisconsin, Madison
- Atridia Pty Ltd.
- Yale University
- Eye & ENT Hospital of Fudan University
- Olivia Newton-John Cancer Research Institute
ClinicalTrialStartPulse: Early phase 1 ClinicalTrialStartPulse: United States sites
More US public-record feeds
U.S. DOT Injury/Illness Summary Pulse in US U.S. DOT FRA Regulated Mode Major Security Events Pulse in US U.S. DOT Crossing Inventory Data Pulse in US U.S. DOT Insur - All With History Pulse in US USAC Telecom CAF Locations Obligation and Deployment by Speed Tier Data Pul in US U.S. CDC 2022 Final Assisted Reproductive Technology Summary Pulse in US U.S. DOT Rail Equipment Accident/Incident Data Subset Pulse in US U.S. DOT Monthly Modal Time Series Pulse in US
How to monitor Ohio State University and peer early phase 1 records
Get new ClinicalTrialStartPulse records like Ohio State University by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.